HMGA2 and acute myeloid leukemia: Several studies have revealed the involvement of HMGA2 in different signaling pathways [9,164,171], but Yang et al. [172] were the first to observe the effect of HMGA2 expression on the WNT/β-catenin pathway in AML, while this effect had already been observed in other types of tumors [173,174].